טוען...
Ligand binding mode prediction by docking: Mdm2/Mdmx inhibitors as a case study
The p53-binding domains of Mdm2 and Mdmx, two negative regulators of the tumor suppressor, p53, are validated targets for cancer therapeutics, but correct binding poses of some proven inhibitors, particularly the nutlins, have been difficult to obtain with standard docking procedures. Virtual screen...
שמור ב:
| הוצא לאור ב: | J Chem Inf Model |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4753531/ https://ncbi.nlm.nih.gov/pubmed/24358984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ci4004656 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|